IDEX Biometrics ASA (IDBA)
NASDAQ: IDBA
· Real-Time Price · USD
4.88
0.08 (1.67%)
At close: Aug 09, 2023, 3:56 PM
IDEX Biometrics ASA Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.31M | 2.18M | 3.25M | 4.14M | 4.7M | 4.7M | 4.34M | 4.09M | 3.81M | 3.62M | 3.21M | 2.84M | 2.65M | 2.17M | 1.59M |
Cost of Revenue | 9.63M | 12.66M | 13.57M | 10.87M | 7.35M | 3.59M | 3.48M | 3.24M | 2.96M | 2.44M | 1.71M | 1.25M | 1M | 747K | 475K |
Gross Profit | -8.32M | -10.48M | -10.32M | -6.73M | -2.65M | 1.11M | 864K | 848K | 853K | 1.18M | 1.5M | 1.59M | 1.65M | 1.42M | 1.12M |
Operating Income | -21.51M | -23.96M | -25.33M | -27.03M | -28.29M | -29.84M | -30.77M | -31.37M | -33.45M | -32.79M | -31.88M | -31.35M | -29.56M | -28.91M | -27.62M |
Interest Income | 126.96K | 183.08K | 222.94K | 255.52K | 245.23K | 218K | 182K | 97K | 61K | 28K | 13K | 12K | 13K | 13K | 11K |
Pretax Income | -15.74M | -23.96M | -24.75M | -26.79M | -27.85M | -30.04M | -31.81M | -32.7M | -36.62M | -35.06M | -33.05M | -32.46M | -29.44M | -28.76M | -27.96M |
Net Income | -15.76M | -23.98M | -24.73M | -26.77M | -27.78M | -29.97M | -31.77M | -32.65M | -36.7M | -35.15M | -33.15M | -32.56M | -29.49M | -28.81M | -27.97M |
Selling & General & Admin | 7.86M | 8.74M | 10.16M | 12.68M | 14.86M | 17.84M | 18.64M | 19.21M | 21.11M | 21.08M | 20.98M | 21.11M | 23.7M | 22.93M | 21.77M |
Research & Development | 2.38M | 1.77M | 1.99M | 2.35M | 2.84M | 3.05M | 3.15M | 3.25M | 3.55M | 3.18M | 3.1M | 2.68M | 2M | 2.27M | 2.46M |
Other Expenses | 2.98M | 2.98M | 7.49K | 2.4M | 5.08M | 7.19M | 9.84M | 9.75M | 9.64M | 9.71M | 9.29M | 9.15M | 6.58M | 4.39M | 2.17M |
Operating Expenses | 13.2M | 13.47M | 15.01M | 20.29M | 25.64M | 30.94M | 31.64M | 32.22M | 34.31M | 33.97M | 33.37M | 32.94M | 31.21M | 30.32M | 28.73M |
Interest Expense | 1.79M | 1.21M | 705.48K | 137.55K | 118.1K | 97K | 53K | 33K | 20K | 17K | 25K | 32K | 461K | 471K | 475K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 764K | 764K | 764K |
Cost & Expenses | 22.83M | 26.13M | 28.58M | 31.16M | 32.99M | 34.53M | 35.12M | 35.46M | 37.27M | 36.41M | 35.08M | 34.19M | 32.21M | 31.07M | 29.21M |
Income Tax Expense | 6.15M | 13.2K | -18.81K | -13.81K | -65.86K | -61K | -31K | -36K | 90K | 97K | 106K | 117K | 73K | 63K | 13K |
Shares Outstanding (Basic) | 313.21M | 291.58M | 279.57M | 279.06M | 266.47M | 258.47M | 233.45M | 214.31M | 180.48M | 173.51M | 202.22M | 193.69M | 149.38M | 144.72M | 174.1M |
Shares Outstanding (Diluted) | 314.07M | 292.34M | 279.57M | 279.06M | 266.47M | 259.02M | 234.09M | 215.01M | 180.48M | 174.61M | 205.33M | 198.68M | 149.38M | 144.72M | 179.69M |
EPS (Basic) | -0.01 | -0.09 | -0.11 | -0.14 | -0.15 | -0.17 | -0.17 | -0.17 | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 |
EPS (Diluted) | -0.01 | -0.09 | -0.11 | -0.14 | -0.15 | -0.17 | -0.17 | -0.17 | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 |
EBITDA | -12.18M | -20.22M | -22.36M | -24.99M | -26.91M | -29.16M | -31.04M | -31.92M | -34.04M | -32.36M | -30.22M | -29.54M | -27.16M | -26.51M | -25.74M |
EBIT | -163.46M | -256.78M | -198.34M | -140.89M | -91.93M | -28.55M | -30.36M | -31.27M | -35.51M | -33.95M | -31.94M | -31.34M | -28.98M | -28.29M | -27.49M |
Depreciation & Amortization | 1.63M | 2.39M | 5.6M | 8.72M | 11.4M | 14.35M | 13.19M | 12.97M | 13.48M | 14.19M | 14.89M | 15.49M | 12.19M | 8.59M | 5.16M |